Fibroma ultrasound: Difference between revisions
Line 8: | Line 8: | ||
On ultrasound, fibromas most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation. | On ultrasound, fibromas most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation. | ||
===Ovarian Fibroma=== | ===Ovarian Fibroma=== | ||
On ultrasound, [[ovarian fibroma]] most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation. As such, they may appear similar to a pedunculated subserosal uterine fibroid. However, the sonographic appearance can be variable and some tumours can rarely have cystic components. | On ultrasound, [[ovarian fibroma]] most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation. As such, they may appear similar to a pedunculated subserosal uterine fibroid. However, the sonographic appearance can be variable and some tumours can rarely have cystic components.<ref name="ChenLiu2016">{{cite journal|last1=Chen|first1=Hui|last2=Liu|first2=Yan|last3=Shen|first3=Li-fei|last4=Jiang|first4=Mei-jiao|last5=Yang|first5=Zhi-fang|last6=Fang|first6=Guo-ping|title=Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison|journal=Journal of Ovarian Research|volume=9|issue=1|year=2016|issn=1757-2215|doi=10.1186/s13048-016-0291-2}}</ref> | ||
===Uterine Fibroma=== | ===Uterine Fibroma=== | ||
*Ultrasound is used to diagnose the presence and monitor the growth of fibromas.<ref name="PengZhang2015">{{cite journal|last1=Peng|first1=Song|last2=Zhang|first2=Lian|last3=Hu|first3=Liang|last4=Chen|first4=Jinyun|last5=Ju|first5=Jin|last6=Wang|first6=Xi|last7=Zhang|first7=Rong|last8=Wang|first8=Zhibiao|last9=Chen|first9=Wenzhi|title=Factors Influencing the Dosimetry for High-Intensity Focused Ultrasound Ablation of Uterine Fibroids|journal=Medicine|volume=94|issue=13|year=2015|pages=e650|issn=0025-7974|doi=10.1097/MD.0000000000000650}}</ref><ref name="Kim2017">{{cite journal|last1=Kim|first1=Young-sun|title=Clinical application of high-intensity focused ultrasound ablation for uterine fibroids|journal=Biomedical Engineering Letters|volume=7|issue=2|year=2017|pages=99–105|issn=2093-9868|doi=10.1007/s13534-017-0012-9}}</ref><ref name="MarshEkpo2013">{{cite journal|last1=Marsh|first1=Erica E.|last2=Ekpo|first2=Geraldine E.|last3=Cardozo|first3=Eden R.|last4=Brocks|first4=Maureen|last5=Dune|first5=Tanaka|last6=Cohen|first6=Leeber S.|title=Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study|journal=Fertility and Sterility|volume=99|issue=7|year=2013|pages=1951–1957|issn=00150282|doi=10.1016/j.fertnstert.2013.02.017}}</ref><ref name="SarkodieBotwe2016">{{cite journal|last1=Sarkodie|first1=Benjamin Dabo|last2=Botwe|first2=Benard Ohene|last3=Ofori|first3=Eric K.|title=Uterine fibroid characteristics and sonographic pattern among Ghanaian females undergoing pelvic ultrasound scan: a study at 3-major centres|journal=BMC Women's Health|volume=16|issue=1|year=2016|issn=1472-6874|doi=10.1186/s12905-016-0288-4}}</ref> | *Ultrasound is used to diagnose the presence and monitor the growth of fibromas.<ref name="PengZhang2015">{{cite journal|last1=Peng|first1=Song|last2=Zhang|first2=Lian|last3=Hu|first3=Liang|last4=Chen|first4=Jinyun|last5=Ju|first5=Jin|last6=Wang|first6=Xi|last7=Zhang|first7=Rong|last8=Wang|first8=Zhibiao|last9=Chen|first9=Wenzhi|title=Factors Influencing the Dosimetry for High-Intensity Focused Ultrasound Ablation of Uterine Fibroids|journal=Medicine|volume=94|issue=13|year=2015|pages=e650|issn=0025-7974|doi=10.1097/MD.0000000000000650}}</ref><ref name="Kim2017">{{cite journal|last1=Kim|first1=Young-sun|title=Clinical application of high-intensity focused ultrasound ablation for uterine fibroids|journal=Biomedical Engineering Letters|volume=7|issue=2|year=2017|pages=99–105|issn=2093-9868|doi=10.1007/s13534-017-0012-9}}</ref><ref name="MarshEkpo2013">{{cite journal|last1=Marsh|first1=Erica E.|last2=Ekpo|first2=Geraldine E.|last3=Cardozo|first3=Eden R.|last4=Brocks|first4=Maureen|last5=Dune|first5=Tanaka|last6=Cohen|first6=Leeber S.|title=Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study|journal=Fertility and Sterility|volume=99|issue=7|year=2013|pages=1951–1957|issn=00150282|doi=10.1016/j.fertnstert.2013.02.017}}</ref><ref name="SarkodieBotwe2016">{{cite journal|last1=Sarkodie|first1=Benjamin Dabo|last2=Botwe|first2=Benard Ohene|last3=Ofori|first3=Eric K.|title=Uterine fibroid characteristics and sonographic pattern among Ghanaian females undergoing pelvic ultrasound scan: a study at 3-major centres|journal=BMC Women's Health|volume=16|issue=1|year=2016|issn=1472-6874|doi=10.1186/s12905-016-0288-4}}</ref> |
Revision as of 17:51, 1 July 2019
Fibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fibroma ultrasound On the Web |
American Roentgen Ray Society Images of Fibroma ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2], Simrat Sarai, M.D. [3]
Overview
Ultrasound may be helpful in the diagnosis of fibroma. Findings on ultrasound suggestive of fibroma include solid, hypoechoic masses with ultrasound beam attenuation.
Ultrasound
On ultrasound, fibromas most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation.
Ovarian Fibroma
On ultrasound, ovarian fibroma most commonly manifest as solid, hypoechoic masses with ultrasound beam attenuation. As such, they may appear similar to a pedunculated subserosal uterine fibroid. However, the sonographic appearance can be variable and some tumours can rarely have cystic components.[1]
Uterine Fibroma
- Uncomplicated leiomyomas are usually hypoechoic, but can be isoechoic, or even hyperechoic compared to normal myometrium
- Calcification is seen as echogenic foci with shadowing
- Cystic areas of necrosis or degeneration may be seen
References
- ↑ Chen, Hui; Liu, Yan; Shen, Li-fei; Jiang, Mei-jiao; Yang, Zhi-fang; Fang, Guo-ping (2016). "Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison". Journal of Ovarian Research. 9 (1). doi:10.1186/s13048-016-0291-2. ISSN 1757-2215.
- ↑ Peng, Song; Zhang, Lian; Hu, Liang; Chen, Jinyun; Ju, Jin; Wang, Xi; Zhang, Rong; Wang, Zhibiao; Chen, Wenzhi (2015). "Factors Influencing the Dosimetry for High-Intensity Focused Ultrasound Ablation of Uterine Fibroids". Medicine. 94 (13): e650. doi:10.1097/MD.0000000000000650. ISSN 0025-7974.
- ↑ Kim, Young-sun (2017). "Clinical application of high-intensity focused ultrasound ablation for uterine fibroids". Biomedical Engineering Letters. 7 (2): 99–105. doi:10.1007/s13534-017-0012-9. ISSN 2093-9868.
- ↑ Marsh, Erica E.; Ekpo, Geraldine E.; Cardozo, Eden R.; Brocks, Maureen; Dune, Tanaka; Cohen, Leeber S. (2013). "Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study". Fertility and Sterility. 99 (7): 1951–1957. doi:10.1016/j.fertnstert.2013.02.017. ISSN 0015-0282.
- ↑ Sarkodie, Benjamin Dabo; Botwe, Benard Ohene; Ofori, Eric K. (2016). "Uterine fibroid characteristics and sonographic pattern among Ghanaian females undergoing pelvic ultrasound scan: a study at 3-major centres". BMC Women's Health. 16 (1). doi:10.1186/s12905-016-0288-4. ISSN 1472-6874.